In a candid revelation that resonates with the struggles of countless individuals around the globe, Oprah Winfrey has shared her personal journey towards maintaining a stable weight during the holiday season—a period notorious for its indulgent feasts and merry overeating. Known for her openness about her weight battles, Winfrey's latest disclosure offers a glimmer of hope and a possible solution for those facing similar challenges.
In December 2023, the media mogul unveiled her strategy for navigating the festive season without the customary weight gain: the use of a GLP-1 medication. This class of drugs, known for its appetite-suppressing properties, represented a turning point for Winfrey, who for the first time in her life did not experience her usual seven to eight pounds of holiday weight gain.
What are GLP-1 Medications?
GLP-1 (Glucagon-Like Peptide-1) medications are a class of drugs primarily used in the treatment of type 2 diabetes and, more recently, for weight management. These medications work by mimicking the action of the naturally occurring hormone GLP-1, which is released from the intestines after eating. GLP-1 plays a crucial role in glucose metabolism and appetite regulation, making these medications effective for both blood sugar control and weight loss.
Photo by: Variety
How Do GLP-1 Agonists Function?
Enhance Insulin Secretion: They stimulate the pancreas to release insulin when blood glucose levels are high. Insulin helps lower blood sugar levels by allowing sugar to move from the blood into the cells.
Reduce Glucagon Secretion: GLP-1 medications suppress the release of glucagon, a hormone that increases blood glucose levels by promoting the release of glucose stored in the liver.
Slow Gastric Emptying: By delaying the emptying of the stomach, these medications extend the sensation of fullness after eating, which can help reduce overall calorie intake.
Appetite Suppression: They act on the brain to decrease appetite, leading to a reduction in food consumption and assisting with weight loss efforts.
GLP-1 medications are typically prescribed in injectable form and taken once daily or weekly, depending on the specific drug. Some well-known GLP-1 medications include liraglutide (marketed for diabetes as Victoza and for weight loss as Saxenda), semaglutide (Ozempic for diabetes, Rybelsus for diabetes in pill form, and Wegovy for weight loss), and dulaglutide (Trulicity).
It's important to note that while GLP-1 medications have shown effectiveness in managing blood sugar levels and aiding weight loss, they are not suitable for everyone and can have side effects. Common side effects include gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. More serious side effects can also occur, though they are less common. Therefore, these medications should only be used under the guidance of a healthcare professional, who can evaluate the benefits and risks based on individual health conditions and needs.
What are the Top GLP-1 Agonists in the Market Today?
several GLP-1 (glucagon-like peptide-1) agonists are prominent in the market for the treatment of type 2 diabetes and, in some cases, for weight management. These medications have gained popularity due to their effectiveness in blood sugar control, weight reduction, and cardiovascular benefits. Below are some of the top GLP-1 agonists available:
Photo By: Healthline
Semaglutide:
Marketed as Ozempic for type 2 diabetes: It's administered via injection once weekly.
Sold as Rybelsus for type 2 diabetes in an oral form, which is notable as the first GLP-1 agonist available in pill form.
Marketed as Wegovy for weight management: It's used at a higher dose than Ozempic for significant weight loss in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
Liraglutide:
Known as Victoza for type 2 diabetes: It requires daily injection.
Marketed as Saxenda for weight management: It's used at a higher dose than Victoza to help adults and some adolescents aged 12 and older with obesity or overweight with at least one weight-related ailment lose weight and keep it off.
Dulaglutide:
Sold under the brand name Trulicity for type 2 diabetes: It's a once-weekly injectable medication.
Exenatide:
Available as Bydureon (an extended-release formulation for once-weekly injection) and Byetta (a twice-daily injectable form) for type 2 diabetes.
Efpeglenatide:
A newer addition to the GLP-1 agonist class, efpeglenatide is marketed under the brand name Mounjaro for the treatment of type 2 diabetes. It's known for its once-weekly injection regimen.
Take Control of Your Goals Right Now
These medications are distinguished by their dosing schedules, administration routes (injection or oral), and some unique effects on weight and cardiovascular health. The choice of a specific GLP-1 agonist depends on various factors, including patient preference, the drug's efficacy and safety profile, cost, and insurance coverage.
It's crucial to consult healthcare professionals for the most appropriate and personalized treatment options, as the landscape of GLP-1 agonists and their approved uses can evolve with ongoing research and regulatory approvals.
Comments